SCOPUS 정보 검색 플랫폼

Volumn 49, Issue 5, 2002, Pages 375-384

The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer

(8) Lewis, Lionel D a Beelen, Andrew P a Cole, Bernard F a Wallace, Paul K a Fisher, Jan L a Waugh, Mary G a Kaufman, Peter A a Ernstoff, Marc S a

a NORRIS COTTON CANCER CENTER (United States)

Author keywords

MDX H210 pharmacokinetics; Phase I study

Indexed keywords

BISPECIFIC ANTIBODY; MDX H 210; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG CARCINOMA; MALE; ONCOGENE NEU; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; STEADY STATE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; BREAST NEOPLASMS; FEMALE; HALF-LIFE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 0036235326 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s00280-002-0424-8 Document Type: Article

Times cited : (14)

References (47)

1
- 0026576399
- HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma
- (1992) J Clin Oncol , vol.10 , pp. 599
- Allred, D.C.¹ Clark, G.M.² Tandon, A.K.³ Molina, R.⁴ Tormey, D.C.⁵ Osborne, C.K.⁶ Gilchrist, K.W.⁷ Mansour, E.G.⁸ Abeloff, M.⁹ Eudey, L.¹⁰ McGuire, W.L.¹¹

2
- 0028180148
- Gamma-interferon inhibits Fc receptor II-mediated phagocytosis of tumor cells by human macrophages
- (1994) Cancer Res , vol.54 , pp. 2456
- Backman, K.A.¹ Guyre, P.M.²

3
- 0029991439
- HER2 monoclonal antibody in patients with HER-2/neu-overexpressing metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 737
- Baselga, J.¹ Tripathy, D.² Mendelsohn, J.³ Baughman, S.⁴ Benz, C.C.⁵ Dantis, L.⁶ Sklarin, N.T.⁷ Seidman, A.D.⁸ Hudis, C.A.⁹ Moore, J.¹⁰ Rosen, P.P.¹¹ Twaddell, T.¹² Henderson, I.C.¹³ Norton, L.¹⁴

4
- 0025373144
- NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffinn-embedded tissue
- (1990) J Pathol , vol.161 , pp. 15
- Corbett, I.P.¹ Henry, J.A.² Angus, B.³ Watchorn, C.J.⁴ Wilkinson, L.⁵ Hennessy, C.⁶ Gullick, W.J.⁷ Tuzi, N.L.⁸ May, F.E.⁹ Westley, B.R.¹⁰ Horne, C.H.¹¹

5
- 0030727901
- Clinical experience with CD64-directed immunotherapy: An overview
- (1997) Cancer Immunol Immunother , vol.45 , pp. 210
- Curnow, R.T.¹

6
- 0025951522
- Bispecific antibodies for targeted cellular cytotoxicity
- (1991) Trends Biotechnol , vol.9 , pp. 375
- Fanger, M.W.¹ Guyre, P.M.²

7
- 0024793661
- Fc gamma R in cytotoxicity exerted by mononuclear cells
- (1989) Chem Immunol , vol.47 , pp. 214
- Fanger, M.W.¹ Graziano, R.F.² Shen, L.³ Guyre, P.M.⁴

8
- 0026027273
- Bispecific antibodies and targeted cellular cytotoxicity
- (1991) Immunol Today , vol.12 , pp. 51
- Fanger, M.W.¹ Segal, D.M.² Romet-Lemonne, J.L.³

9
- 0028280166
- Production and use of anti-FcR bispecific antibodies
- (1994) Immunomethods , vol.4 , pp. 72
- Fanger, M.W.¹ Graziano, R.F.² Guyre, P.M.³

10
- 0028960226
- Mature polymorphonuclear leukocytes express high-affinity receptors for IgG (FcγRI) after stimulation with granulocyte colony stimulating factor (G-CSF)
- (1995) J Leukoc Biol , vol.57 , pp. 455
- Gericke, G.H.¹ Ericson, S.G.² Pan, L.³ Mills, L.E.⁴ Guyre, P.M.⁵ Ely, P.⁶

11
- 0031449358
- FcRn: The MHC class I-related receptor that is more than an IgG transporter
- (1997) Immunol Today , vol.18 , pp. 592
- Ghetie, V.¹ Ward, E.S.²

12
- 0034042660
- Multiple roles for the major histocompatibility complex class I-related receptor FcRn
- (2000) Annu Rev Immunol , vol.18 , pp. 739
- Ghetie, V.¹ Ward, E.S.²

13
- 0023616796
- Preparation and performance of bispecific F(ab′γ)2 antibody containing thioether-linked Fab′γ fragments
- (1987) J Immunol , vol.139 , pp. 2367
- Glennie, M.J.¹ McBride, H.M.² Worth, A.T.³ Stevenson, G.T.⁴

14
- 0026625217
- Prognostic importance of c-erbB-2 expression in breast cancer
- (1992) J Clin Oncol , vol.10 , pp. 1049
- Gusterson, B.A.¹ Gelber, R.D.² Goldhirsch, A.³ Price, K.N.⁴ Säve-Söderborgh, J.⁵ Anbazhagan, R.⁶ Styles, J.⁷ Rudenstam, C.M.⁸ Golouh, R.⁹ Reed, R.¹⁰ Martinez-Tello, F.¹¹ Tiltman, A.¹² Torhorst, J.¹³ Grigolato, P.¹⁴ Bettelheim, R.¹⁵ Neville, A.M.¹⁶ Bürki, K.¹⁷ Castiglione, M.¹⁸ Collins, J.¹⁹ Lindtner, J.²⁰ Senn, H.J.²¹ more..

15
- 0024416006
- Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function
- (1989) J Immunol , vol.143 , pp. 1650
- Guyre, P.M.¹ Graziano, R.F.² Vance, B.A.³ Morganelli, P.M.⁴ Fanger, M.W.⁵

16
- 0025666857
- Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors
- (1990) J Clin Invest , vol.86 , pp. 1892
- Guyre, P.M.¹ Campbell, A.S.² Kniffin, W.D.³ Fanger, M.W.⁴

17
- 0030974954
- Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody
- (1997) Blood , vol.89 , pp. 2042
- Hartmann, F.¹ Renner, J.C.² Jung, W.³ Deisting, G.⁴ Juwana, M.⁵ Eichentopf, B.⁶ Kloft, M.⁷ Pfreundschuh, M.⁸

18
- 0031297669
- Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: Efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies
- (1997) J Immunol , vol.159 , pp. 5629
- Heijnen, I.A.¹ Rijks, L.J.² Schiel, A.³ Stockmeyer, B.⁴ Van Ojik, H.H.⁵ Dechant, M.⁶ Valerius, T.⁷ Keler, T.⁸ Tutt, A.L.⁹ Glennie, M.J.¹⁰ Van Royen, E.A.¹¹ Capel, P.J.¹² Van de Winkel, J.G.¹³

19
- 0027080080
- In vitro cytotoxic targeting by human mononuclear cells and bispecific antibody 2B1, recognizing c-erbB-2 protooncogene product and Fc gamma receptor III
- (1992) Cancer Res , vol.52 , pp. 6832
- Hsieh Ma, S.T.¹ Eaton, A.M.² Shi, T.³ Ring, D.B.⁴

20
- 0034940408
- A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancer
- (2001) Br J Cancer , vol.85 , pp. 152
- James, N.¹ Atherton, P.² Jones, J.³ Howie, A.J.⁴ Tchekmedyian, S.⁵ Curnow, R.T.⁶

21
- 85017263125
- HER-2/neu targeted immunotherapy: A pilot study of multi-dose MDX-210 in patients with breast or ovarian cancers that overexpress HER-2/neu and a report of an increased incidence of HER-2/neu overexpression in metastatic breast cancer
- (1996) Tumor Targeting , vol.2 , pp. 17
- Kaufman, P.A.¹ Guyre, P.M.² Lewis, L.D.³ Valone, F.H.⁴ Memoli, V.⁵ Wells, W.⁶ Deo, Y.M.⁷ Ernstoff, M.S.⁸ Fisher, J.⁹ Mrozek-Orlowski, M.¹⁰ Phipps, K.¹¹ Fanger, M.W.¹²

22
- 0008908624
- Phase-I trial of interferon gamma (IFNγ) and MDX-210 (anti-HER-2/neu x anti-FcγRI) in patients (pts) with metastatic carcinomas that overexpress HER-2/neu: Preliminary findings
- abstract 1542
- (1997) Proc Am Soc Clin Oncol , vol.16 , pp. 430a
- Kaufman, P.A.¹ Guyre, P.M.² Barth, R.J.³ Lewis, L.D.⁴ Memoli, V.⁵ Curnow, R.T.⁶ Deo, Y.⁷ Harris, R.⁸ Valone, F.⁹ Wallace, P.K.¹⁰ Wells, W.¹¹ Schned, A.¹² Fisher, J.¹³ Waugh, M.¹⁴ Phipps, K.¹⁵ Mackay, K.¹⁶ Fanger, M.W.¹⁷ Ernstoff, M.S.¹⁸

23
- 0030858083
- Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing eHector cells
- (1997) Cancer Res , vol.57 , pp. 4008
- Keler, T.¹ Graziano, R.F.² Mandal, A.³ Wallace, P.K.⁴ Fisher, J.⁵ Guyre, P.M.⁶ Fanger, M.W.⁷ Deo, Y.M.⁸

24
- 0027476531
- Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen) positive neutrophils via an effect on myeloid precursor cells
- (1993) Blood , vol.81 , pp. 1457
- Kerst, J.M.¹ Van de Winkel, J.G.² Evans, A.H.³ De Haas, M.⁴ Slaper-Cortenbach, I.C.⁵ De Wit, T.P.⁶ Von dem Borne, A.E.⁷ Van der Schoot, C.E.⁸ Van Oers, R.H.⁹

25
- 0035251812
- Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: A multiple dose phase-I study in patients with advanced cancer which overexpresses Her-2/neu
- (2001) J Immunol Methods , vol.248 , pp. 149
- Lewis, L.D.¹ Cole, B.F.² Wallace, P.K.³ Fisher, J.L.⁴ Waugh, M.W.⁵ Guyre, P.M.⁶ Fanger, M.W.⁷ Curnow, R.T.⁸ Kaufman, P.A.⁹ Ernstoff, M.S.¹⁰

26
- 0022571152
- Human monocytes and U937 cells bear two distinct Fc receptors for IgG
- (1986) J Immunol , vol.136 , pp. 1641
- Looney, R.J.¹ Abraham, G.N.² Anderson, C.L.³

27
- 0021016604
- Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors
- (1983) J Immunol , vol.131 , pp. 2983
- Lopez, A.F.¹ Nicola, N.A.² Burgess, A.W.³ Metcalf, D.⁴ Battye, F.L.⁵ Sewell, W.E.⁶ Vadas, M.⁷

28
- 0025949244
- Recombinant human granulocyte colony-stimulating factor inhibits the metastasis of hematogenous and non-hematogenous tumors in mice
- (1991) Int J Cancer , vol.49 , pp. 444
- Matsumoto, Y.¹ Saiki, I.² Murata, J.³ Okuyama, H.⁴ Tamura, M.⁵ Azuma, I.⁶

29
- 0020564130
- Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells
- (1983) J Exp Med , vol.158 , pp. 1092
- Perussia, B.¹ Dayton, E.T.² Lazarus, R.³ Fanning, V.⁴ Trinchieri, G.⁵

30
- 0032995774
- A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies
- (1999) J Immunother , vol.22 , pp. 371
- Posey, J.A.¹ Raspet, R.² Verma, U.³ Deo, Y.M.⁴ Keller, T.⁵ Marshall, J.L.⁶ Hodgson, J.⁷ Mazumder, A.⁸ Hawkins, M.J.⁹

31
- 0032919486
- A phase I study of a HER-2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER-2/neu
- (1999) Cancer Immuno Immunother , vol.48 , pp. 9
- Pullarkat, V.¹ Deo, Y.² Link, J.³ Spears, L.⁴ Marty, V.⁵ Curnow, R.⁶ Groshen, S.⁷ Gee, C.⁸ Weber, J.S.⁹

32
- 0025817427
- Fc receptors
- (1991) Annu Rev Immunol , vol.9 , pp. 457
- Ravetch, J.V.¹ Kinet, J.P.²

33
- 0026000790
- Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor
- (1991) Blood , vol.78 , pp. 885
- Repp, R.¹ Valerius, T.² Sendler, A.³ Gramatzki, M.⁴ Iro, H.⁵ Kalden, J.R.⁶ Platzer, E.⁷

34
- 0035134203
- Phase I pilot trial of the bispecific antibody MDXH210 (anti-FcγRI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu
- (2001) J Immunother , vol.24 , pp. 79
- Schwaab, T.¹ Lewis, L.D.² Cole, B.F.³ Deo, Y.⁴ Fanger, M.W.⁵ Wallace, P.⁶ Guyre, P.M.⁷ Kaufman, P.A.⁸ Heaney, J.A.⁹ Schned, A.R.¹⁰ Harris, R.D.¹¹ Ernstoff, M.S.¹²

35
- 0022981191
- Heteroantibody-mediated cytotoxicity: Antibody to the high-affinity Fc receptor for IgG mediates cytotoxicity by human monocytes which is enhanced by interferon-gamma and is not blocked by human IgG
- (1986) J Immunol , vol.137 , pp. 3378
- Shen, L.¹ Guyre, P.M.² Anderson, C.L.³ Fanger, M.W.⁴

36
- 0024387291
- The functional properties of Fc gamma RI, II and III on myeloid cells: A comparative study of killing of erythrocytes and tumor cells mediated through the different Fc receptors
- (1989) Mol Immunol , vol.26 , pp. 959
- Shen, L.¹ Graziano, R.F.² Fanger, M.W.³

37
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
- (1987) Science , vol.235 , pp. 177
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

38
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science , vol.244 , pp. 707
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶ Levin, W.J.⁷ Stuart, S.G.⁸ Udove, J.⁹ Ullrich, A.¹⁰ Press, M.F.¹¹

39
- 0032713216
- Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
- (1999) Br J Cancer , vol.81 , pp. 1419
- Tokuda, Y.¹ Watanabe, T.² Omuro, Y.³ Ando, M.⁴ Katsumata, N.⁵ Okumura, A.⁶ Ohta, M.⁷ Fujii, H.⁸ Sasaki, Y.⁹ Niwa, T.¹⁰ Tajima, T.¹¹

40
- 0027304602
- Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy
- (1993) Blood , vol.82 , pp. 931
- Valerius, T.¹ Repp, R.² De Wit, T.P.³ Berthold, S.⁴ Platzer, E.⁵ Kalden, J.R.⁶ Gramatzki, M.⁷ Van de Winkel, J.G.⁸

41
- 0029095589
- Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
- (1995) J Clin Oncol , vol.13 , pp. 2281
- Valone, F.H.¹ Kaufman, P.A.² Guyre, P.M.³ Lewis, L.D.⁴ Memoli, V.⁵ Deo, Y.⁶ Graziano, R.⁷ Fisher, J.L.⁸ Meyer, L.⁹ Mrozek-Orlowski, M.¹⁰ Wardwell, K.¹¹ Guyre, V.¹² Morley, T.L.¹³ Arvizu, C.¹⁴ Fanger, M.W.¹⁵

42
- 0028805090
- Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu
- (1995) J Hematother , vol.4 , pp. 471
- Valone, F.H.¹ Kaufman, P.A.² Guyre, P.M.³ Lewis, L.D.⁴ Memoli, V.⁵ Eernstoff, M.S.⁶ Wells, W.⁷ Barth, R.⁸ Deo, Y.⁹ Fisher, J.¹⁰

43
- 0025921573
- Biology of human immunoglobulin G Fc receptors
- (1991) J Leukoc Biol , vol.49 , pp. 511
- Van de Winkel, J.G.¹ Anderson, C.L.²

44
- 0030829805
- Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer
- (1997) Cancer Immunol Immunother , vol.45 , pp. 207
- Van Ojik, H.H.¹ Repp, R.² Groenewegen, G.³ Valerius, T.⁴ Van de Winkel, J.G.⁵

45
- 0033859727
- Immunotherapeutic perspective for bispecific antibodies
- (2000) Immunol Today , vol.21 , pp. 391
- Van Spriel, A.B.¹ Van Ojik, H.H.² Van de Winkel, J.G.³

46
- 0032944540
- Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210
- (1999) Breast Cancer Res Treat , vol.53 , pp. 199
- Watanabe, M.¹ Wallace, P.K.² Keler, T.³ Deo, Y.M.⁴ Akewanlop, C.⁵ Hayes, D.F.⁶

47
- 0033063774
- The epidermal growth factor receptor and its inhibition in cancer therapy
- (1999) Pharmacol Ther , vol.82 , pp. 241
- Woodburn, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.